Clinical Trial Update: Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating safety and efficacy of rhNGF eye drops at different doses for dry eye syndrome; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• rhNGF eye drops (nerve growth factor)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2019-08-07